Abstract
Idiopathic intracranial hypertension (IIH) is a condition characterized by a constellation of symptoms including headache, visual disturbance, tinnitus, and papilledema that affect primarily obese/young female. The pathophysiologic hallmark of the disease is a chronic elevation of intracranial pressure (opening pressure on lumbar puncture >250 cm H2O). Despite the significant morbidity associated with this condition (vision loss and debilitating headaches), the exact mechanisms leading high intracranial pressure is not known. It has been purported that cerebral venous stenosis (CVS) may play a role in the pathogenesis of idiopathic intracranial hypertension. In this chapter, we examine the evidence linking cerebral venous stenosis to IIH. From an epidemiological perspective, CVS is up to 9 times more prevalent among patients with IIH compared to their counterparts, and the cerebral venous pressure gradient across the stenotic segment by venographic manometry is higher among patients with IIH. Pathophysiological evidence for an association between CVS and IIH suggest that at least in some cases, variations in the caliber of the cerebral vein is associated with a change in cerebrospinal fluid pressure; an observation that is supported by mathematical models. In the absence of randomized clinical trials, the best evidence supporting CVS stenting are primarily provided by meta-analyses of individual studies that report a clinical benefit of the procedure albeit several shortfalls. In light of the suggested association between cerebral transverse sinus stenosis/hypoplasia and certain IIH cases, future research would need to focus on defining the clinical and radiological profile of individuals who will best benefit from CVS stenting. It is also expected that ongoing clinical trials shed more light on the association between CVS and IIH and refine the therapeutic potentials of stenting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–5.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78–91.
Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24(2):138–45.
Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. 2008;8(2):87–93.
Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol. 2001;21(1):12–4.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875–7.
Asensio-Sanchez VM, Merino-Angulo J, Martinez-Calvo S, Calvo MJ, Rodriguez R. [Epidemiology of pseudotumor cerebri]. Arch Soc Esp Oftalmol. 2007;82(4):219–21.
Craig JJ, Mulholland DA, Gibson JM. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulster Med J. 2001;70(1):31–5.
Idiculla T, Zachariah G, Br K, Mohamood N. The incidence and prevalance of idiopathic intracranial hypertension in south Sharaqiah region, Oman. Oman J Ophthalmol. 2013;6(3):189–92.
Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116(1):18–28.
Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol. 2004;14(1):48–54.
Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology. 2008;70(8):634–40.
Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011;76(18):1564–7.
Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–41.
Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology. 2004;63(9):1737–9.
Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1–11.
Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60(9):1418–24.
Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology. 2006;67(3):419–23.
Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol. 2008;255(6):807–12.
Kelly LP, Saindane AM, Bruce BB, et al. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure? Clin Neurol Neurosurg. 2013;115(8):1215–9.
Levitt MR, Hlubek RJ, Moon K, et al. Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms. J Neurosurg. 2017;126:347–53.
Joynt RJ, Sahs AL. Brain swelling of unknown cause. Neurology. 1956;6(11):801–3.
Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol. 1995;52(2):141–5.
Sørensen PS, Thomsen C, Gjerris F, Henriksen O. Brain water accumulation in pseudotumour cerebri demonstrated by MR-imaging of brain water self-diffusion. Acta Neurochir Suppl (Wien). 1990;51:363–5.
Sørensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O. Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res. 1989;11(3):160–4.
Gideon P, Sørensen PS, Thomsen C, Ståhlberg F, Gjerris F, Henriksen O. Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 1995;16(2):381–7.
Bastin ME, Sinha S, Farrall AJ, Wardlaw JM, Whittle IR. Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study. J Neurol Neurosurg Psychiatry. 2003;74(12):1693–6.
De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005;25(6):342–4.
Scoffings DJ, Pickard JD, Higgins JN. Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2007;78(8):911–2.
Lee SW, Gates P, Morris P, Whan A, Riddington L. Idiopathic intracranial hypertension; immediate resolution of venous sinus “obstruction” after reducing cerebrospinal fluid pressure to<10cmH(2)O. J Clin Neurosci. 2009;16(12):1690–2.
Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology. 2004;62(8):1445–6.
Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology. 2005;65(7):1090–3.
Connor SE, Siddiqui MA, Stewart VR, O’Flynn EA. The relationship of transverse sinus stenosis to bony groove dimensions provides an insight into the aetiology of idiopathic intracranial hypertension. Neuroradiology. 2008;50(12):999–1004.
Stevens SA, Stimpson J, Lakin WD, Thakore NJ, Penar PL. A model for idiopathic intracranial hypertension and associated pathological ICP wave-forms. IEEE Trans Biomed Eng. 2008;55(2 Pt 1):388–98.
Stevens SA, Thakore NJ, Lakin WD, Penar PL, Tranmer BI. A modeling study of idiopathic intracranial hypertension: etiology and diagnosis. Neurol Res. 2007;29(8):777–86.
Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.
Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094–8.
Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7.
Committee NIIHSGW, Wall M, McDermott MP, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.
Hainline C, Rucker JC, Balcer LJ. Current concepts in pseudotumor cerebri. Curr Opin Neurol. 2016;29(1):84–93.
Iancu D, Schwarz BA. Stenting of venous sinus stenosis for medically refractory idiopathic intracranial hypertension. Ottawa: Ottawa Hospital Research Institute; 2014.
Patsalides A. Venous sinus stenting for idiopathic intracranial hypertension refractory to medical therapy (VSSIIH). New York: Weill Cornell Medical College; 2011.
Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg. 2013;5(5):483–6.
Satti SR, Leishangthem L, Chaudry MI. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2015;36(10):1899–904.
Acknowledgments
We would like to thank Drs. Samir Belagaje and Saher Khalid for their generous comments on this manuscript. Dr. Feng would like to acknowledge the grant supports from National Institute of Health (P20GM109040 and HD086844), American Heart Association (14SDG1829003) and South Carolina Clinical & Translational Research Institute (UL1 TR001450).
Disclosure
None
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
1.1 Search Terms
#1 “pseudotumor cerebri” OR “idiopathic intracranial hypertension” OR “benign intracranial hypertension”
#2 “venous stenosis” OR “sinus stenosis” OR “stenosis of cerebral vein”
#3 1 AND 2
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Lekoubou, A., Feng, W. (2019). Idiopathic Intracranial Hypertension: A Venous Disease?. In: Lou, M., et al. Cerebral Venous System in Acute and Chronic Brain Injuries. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-96053-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-96053-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-96052-4
Online ISBN: 978-3-319-96053-1
eBook Packages: MedicineMedicine (R0)